Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Intravenous lidocaine with ropivacaine at the port sites for recovery after laparoscopic colorectal surgery

Official title: Evaluation of Postoperative Recovery When Combining Intravenous Lidocaine With Ropivacaine Infiltrations in Colorectal Laparoscopic Surgery

Run by Centre Hospitalier Universitaire, Amiens · NCT07414706 · Data updated 2026-11-12

This trial tests whether giving an IV lidocaine during surgery plus ropivacaine at the port sites improves recovery after laparoscopic colorectal cancer surgery compared with ropivacaine at the port sites alone.

More Laparoscopic Surgery trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment182 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedSeptember 22, 2026
Main results expectedJune 2028
Study endsSeptember 2028
Registry record updatedOctober 16, 2026
Trial IDNCT07414706 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing scheduled laparoscopic colorectal cancer surgery who can consent and have access to the social security system.

Probably not a fit

Patients who do not experience improved recovery or have safety concerns related to lidocaine exposure may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this phase 3 randomized study, adults undergoing scheduled laparoscopic colorectal cancer surgery are assigned 1:1 to receive perioperative IV lidocaine infusion with port-site ropivacaine infiltration or port-site ropivacaine infiltration alone. The lidocaine is given as an induction bolus followed by a continuous infusion during surgery and stopped at closure. All patients receive standard anesthesia and multimodal postoperative pain control. The primary outcome is quality of recovery via QoR-15, with secondary measures including pain, opioid use, and systemic lidocaine and ropivacaine levels to monitor safety.

Why it matters

Potential benefit: If successful, the approach could improve postoperative recovery and reduce pain and opioid needs after laparoscopic colorectal surgery.

How similar studies have gone: Previous similar strategies using perioperative lidocaine and local anesthetics have shown potential benefits, but results vary by surgical context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient undergoing scheduled colorectal cancer surgery via laparoscopy.
* Patient aged 18 years or older.
* Informed consent obtained and signed.
* Affiliation to a social security system.

Exclusion Criteria:

* Allergy or contraindication to lidocaine or ropivacaine.
* Allergy or contraindication to paracetamol, nefopam ketamine, propofol, dexamethasone, sufentanil, Celebrex or parecoxib, morphine derivatives, and colorectal surgery by laparotomy
* Colorectal surgery with a non-cancerous indication.
* Chronic preoperative pain (defined as persistent pain for more than 3 months).
* Preoperative use of opioids or opioid derivatives.
* Patients with psychiatric disorders.
* Patients for whom self-assessment of pain using a self-reported scale cannot be performed (non-communicative, non-French speaking, etc.).
* Pregnant or breastfeeding women.
* Patients under guardianship, curatorship, or legal protection.

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.